2J4-25509-47718
2 vaccinations
2 coded responses
16 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 524 / IA
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Pfizer-BioNTech
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2021-01-06
-
2021-01-13
Dose 2 — Pfizer-BioNTech
- 2021-02-04
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-04-14
-
2021-07-14
Survey response — 6 months, dose 2MedDRA: Anosmia, Cough, Nasopharyngitis, Rhinorrhoea, Sinus headache — Feeling: FairFree text: Currently have cold symptoms - runny nose, cough, sinus headache. No fever or loss of smell. Have not been tested for COVID.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2022-01-13
Survey response — 12 months, dose 2MedDRA: Cough, Oropharyngeal pain, Rhinorrhoea, Sneezing — Feeling: GoodFree text: Booster 10/21/21. Starting 12/24/21, sore throat with occasional coughing, runny nose, rare sneezing. Lasted two weeks. Did not COVID test, shortage of tests at my work (a hospital), pharmacies out of at-home kits. On vacation first week anyway.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-13 | Pfizer-BioNTech |
Free text
Release 9 — 6 months, dose 2
Symptoms: Currently have cold symptoms - runny nose, cough, sinus headache. No fever or loss of smell. Have not been tested for COVID.
Release 10 — 12 months, dose 2
Symptoms: Booster 10/21/21. Starting 12/24/21, sore throat with occasional coughing, runny nose, rare sneezing. Lasted two weeks. Did not COVID test, shortage of tests at my work (a hospital), pharmacies out of at-home kits. On vacation first week anyway.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | ○ | ○ | ○ |
| SD | Anosmia | ○ | ○ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Headache | ○ | ○ | ○ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ○ | ○ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | ○ | ○ | ○ |
| SD | Sinus headache | ✓ | ✓ | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release